Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2021 May 17

PMID 33993770

Authors

Erin L Tomaszewski

Trevor J Orchard

Marquis S Hawkins

Rebecca B N Conway

Jeanine M Buchanich

John Maynard

Thomas Songer

Tina Costacou

Affiliations

Soon will be listed here.

Abstract

Background: Skin intrinsic fluorescent (SIF) scores are indirect measures of advanced glycation end-products (AGEs). SIF scores are cross-sectionally associated with type 1 diabetes (T1D) complications such as increased albumin excretion rate (AER), coronary artery calcification (CAC) and neuropathy. We assessed predictors of SIF score change in those with T1D.

Methods: Data from the 30-year longitudinal Epidemiology of Diabetes Complications (EDC) study of childhood-onset T1D were used to assess AGEs measured with a SIF score produced by the SCOUT DS® device. SIF scores were assessed twice in 83 participants: between 2007-08 and again between 2010-14. Regression analyses were used to assess independent predictors of SIF score change.

Results: At baseline, mean age was 47.9 ± 6.9 years, diabetes duration was 36.7 ± 6.4 years, and median glycosylated hemoglobin (HbA1c) was 7.1 (interquartile range: 6.5, 8.5). During a mean follow-up of 5.2 ± 0.9 years, mean change in SIF score was 2.9 ± 2.8 arbitrary units. In multivariable linear regression models, log HbA1c ( < 0.001), log estimated glomerular filtration rate (eGFR) ( < 0.001), overt nephropathy (defined as AER ≥ 200 µg/min, = 0.06), and multiple daily insulin shots/pump use (MDI) exposure years ( = 0.02) were independent predictors of SIF score change.

Conclusions: Increases in SIF score over 5 years were related to increased glycemic levels and decreased kidney function (eGFR). MDI and glomerular damage were related to a decreased SIF score. This is one of the first studies with repeated SIF assessments in T1D and provides unique, albeit preliminary, insight about these associations.

References

Rogers M, Kim C, Banerjee T, Lee J . Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med. 2017; 15(1):199. PMC: 5688827. DOI: 10.1186/s12916-017-0958-6. View

Rajaobelina K, Helmer C, Velayoudom-Cephise F, Nov S, Farges B, Pupier E . Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes. Diabetes Metab Res Rev. 2017; 33(7). DOI: 10.1002/dmrr.2917. View

Warnick G, Albers J . Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem. 1978; 24(6):900-4. View

Fournet M, Bonte F, Desmouliere A . Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging. Aging Dis. 2018; 9(5):880-900. PMC: 6147582. DOI: 10.14336/AD.2017.1121. View

Maahs D, West N, Lawrence J, Mayer-Davis E . Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010; 39(3):481-97. PMC: 2925303. DOI: 10.1016/j.ecl.2010.05.011. View

Smit A, Smit J, Botterblom G, Mulder D . Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes. PLoS One. 2013; 8(6):e65592. PMC: 3672176. DOI: 10.1371/journal.pone.0065592. View

ALLAIN C, Poon L, Chan C, Richmond W, Fu P . Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20(4):470-5. View

Orchard T, Dorman J, Maser R, Becker D, Drash A, Ellis D . Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990; 39(9):1116-24. DOI: 10.2337/diab.39.9.1116. View

Cleary P, Braffett B, Orchard T, Lyons T, Maynard J, Cowie C . Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Technol Ther. 2013; 15(6):466-74. PMC: 4428254. DOI: 10.1089/dia.2012.0316. View

10.

HULL E, Ediger M, Unione A, Deemer E, Stroman M, Baynes J . Noninvasive, optical detection of diabetes: model studies with porcine skin. Opt Express. 2009; 12(19):4496-510. DOI: 10.1364/opex.12.004496. View

11.

Orchard T, Dorman J, Maser R, Becker D, Ellis D, LaPorte R . Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care. 1990; 13(7):741-7. DOI: 10.2337/diacare.13.7.741. View

12.

Ellis D, Coonrod B, Dorman J, Kelsey S, Becker D, Avner E . Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis. 1989; 13(4):321-8. DOI: 10.1016/s0272-6386(89)80039-3. View

13.

. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes. 1986; 35(5):530-45. View

14.

Aroda V, Conway B, Fernandez S, Matter N, Maynard J, Orchard T . Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. Diabetes Technol Ther. 2013; 15(2):117-23. PMC: 3558674. DOI: 10.1089/dia.2012.0211. View

15.

Vollenbrock C, van Waateringe R, Veeze H, Aanstoot H, Wolffenbuttel B . Skin autofluorescence is increased in young people with type 1 diabetes exposed to secondhand smoking. J Diabetes. 2016; 9(3):308-310. DOI: 10.1111/1753-0407.12498. View

16.

Monnier V, Genuth S, Sell D . The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes. Glycoconj J. 2016; 33(4):569-79. PMC: 5080659. DOI: 10.1007/s10719-016-9702-2. View

17.

Williams K, Erbey J, Becker D, Arslanian S, Orchard T . Can clinical factors estimate insulin resistance in type 1 diabetes?. Diabetes. 2000; 49(4):626-32. DOI: 10.2337/diabetes.49.4.626. View

18.

Orchard T, Forrest K, Ellis D, Becker D . Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited. Arch Intern Med. 1997; 157(16):1851-6. View

19.

Xin C, Wang Y, Liu M, Zhang B, Yang S . Correlation analysis between advanced glycation end products detected noninvasively and skin aging factors. J Cosmet Dermatol. 2020; 20(1):243-248. DOI: 10.1111/jocd.13452. View

20.

Maffi P, Secchi A . The Burden of Diabetes: Emerging Data. Dev Ophthalmol. 2017; 60:1-5. DOI: 10.1159/000459641. View